Showing results (1091-1100 of 6,768) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|May 13, 2023
Use of Antidepressants and the Risk of Upper Gastrointestinal Tract Bleeding: A Case-control StudyMarcela Forgerini, Geovana Schiavo, Gustavo Urbano, et al.Clinical Therapeutics|January 1, 1986
Urinary response to oral potassium citrate therapy for urolithiasis in a private practice settingM J Nicar, M C Hsu, C FetnerClinical Therapeutics|November 17, 2012
Limited sampling estimates of epigallocatechin gallate exposures in cirrhotic and noncirrhotic patients with hepatitis C after single oral doses of green tea extractDina Halegoua-De Marzio, Walter K Kraft, Constantine Daskalakis, et al.Clinical Therapeutics|May 28, 2014
Potential of cancer cell-derived exosomes in clinical application: a review of recent research advancesYu Sun, Jing LiuClinical Therapeutics|January 15, 2014
An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screeningGweneth B Lazenby, Peyton T Taylor, Barbara S Badman, et al.Clinical Therapeutics|June 21, 2014
Effects of moderate hepatic impairment on the pharmacokinetic properties and tolerability of umeclidinium and vilanterol in inhalational umeclidinium monotherapy and umeclidinium/vilanterol combination therapy: an open-label, nonrandomized studyRashmi Mehta, Kelly Hardes, Dennis Kelleher, et al.Clinical Therapeutics|June 21, 2014
The cost of blood collection in Greece: an economic analysisVassilis Fragoulakis, Kostas Stamoulis, Elisabeth Grouzi, et al.Clinical Therapeutics|June 23, 2014
Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cellsMorten P Oksvold, Anette Kullmann, Lise Forfang, et al.Clinical Therapeutics|July 1, 2014
Pharmacokinetic interaction between rosuvastatin and metformin in healthy Korean male volunteers: a randomized, open-label, 3-period, crossover, multiple-dose studyDonghwan Lee, Hyerang Roh, Hankil Son, et al.Clinical Therapeutics|July 13, 2020
Comparative Cost-utility Analysis of Regorafenib and Trifluridine/Tipiracil in The Treatment of Metastatic Colorectal Cancer in JapanMunenobu Kashiwa, Ryo MatsushitaPageof 677